A historically significant milestone has just been reached by Oxford, UK-based Exscientia, which used its artificial intelligence (AI)-based drug discovery …
In 1970-80s, the idea of virtual screening was regarded as a conceptual way to substitute costly and time-consuming experimental “screen-everything-you-have” …
This website uses cookies
We use cookies to personalise content and to analyse our traffic. We also share information about your use of our site
with our analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected
from your use of their services. You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.